476 related articles for article (PubMed ID: 24623107)
81. In vitro and in vivo activities of pterostilbene against Candida albicans biofilms.
Li DD; Zhao LX; Mylonakis E; Hu GH; Zou Y; Huang TK; Yan L; Wang Y; Jiang YY
Antimicrob Agents Chemother; 2014; 58(4):2344-55. PubMed ID: 24514088
[TBL] [Abstract][Full Text] [Related]
82. Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency.
Tabbene O; Azaiez S; Di Grazia A; Karkouch I; Ben Slimene I; Elkahoui S; Alfeddy MN; Casciaro B; Luca V; Limam F; Mangoni ML
J Appl Microbiol; 2016 Feb; 120(2):289-300. PubMed ID: 26669801
[TBL] [Abstract][Full Text] [Related]
83. Utilising polyphenols for the clinical management of Candida albicans biofilms.
Shahzad M; Sherry L; Rajendran R; Edwards CA; Combet E; Ramage G
Int J Antimicrob Agents; 2014 Sep; 44(3):269-73. PubMed ID: 25104135
[TBL] [Abstract][Full Text] [Related]
84. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
85. Environmental pH influences Candida albicans biofilms regarding its structure, virulence and susceptibility to fluconazole.
de Vasconcellos AA; Gonçalves LM; Del Bel Cury AA; da Silva WJ
Microb Pathog; 2014; 69-70():39-44. PubMed ID: 24685701
[TBL] [Abstract][Full Text] [Related]
86. Usnic Acid Activity on Oxidative and Nitrosative Stress of Azole-Resistant Candida albicans Biofilm.
Peralta MA; da Silva MA; Ortega MG; Cabrera JL; Paraje MG
Planta Med; 2017 Feb; 83(3-04):326-333. PubMed ID: 27648556
[TBL] [Abstract][Full Text] [Related]
87. Dodonaea viscosa var angustifolia derived 5,6,8-trihydroxy-7,4' dimethoxy flavone inhibits ergosterol synthesis and the production of hyphae and biofilm in Candida albicans.
Patel M; Srivastava V; Ahmad A
J Ethnopharmacol; 2020 Sep; 259():112965. PubMed ID: 32413575
[TBL] [Abstract][Full Text] [Related]
88. Lipopeptide production by Bacillus subtilis R1 and its possible applications.
Jha SS; Joshi SJ; S J G
Braz J Microbiol; 2016; 47(4):955-964. PubMed ID: 27520530
[TBL] [Abstract][Full Text] [Related]
89. Endophytic Bacillus spp. produce antifungal lipopeptides and induce host defence gene expression in maize.
Gond SK; Bergen MS; Torres MS; White JF
Microbiol Res; 2015 Mar; 172():79-87. PubMed ID: 25497916
[TBL] [Abstract][Full Text] [Related]
90. Antimicrobial, antiadhesive and antibiofilm potential of lipopeptides synthesised by Bacillus subtilis, on uropathogenic bacteria.
Moryl M; Spętana M; Dziubek K; Paraszkiewicz K; Różalska S; Płaza GA; Różalski A
Acta Biochim Pol; 2015; 62(4):725-32. PubMed ID: 26505130
[TBL] [Abstract][Full Text] [Related]
91. 5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans.
Subramenium GA; Swetha TK; Iyer PM; Balamurugan K; Pandian SK
Microbiol Res; 2018 Mar; 207():19-32. PubMed ID: 29458854
[TBL] [Abstract][Full Text] [Related]
92. Surfactin effectively inhibits Staphylococcus aureus adhesion and biofilm formation on surfaces.
Liu J; Li W; Zhu X; Zhao H; Lu Y; Zhang C; Lu Z
Appl Microbiol Biotechnol; 2019 Jun; 103(11):4565-4574. PubMed ID: 31011774
[TBL] [Abstract][Full Text] [Related]
93. Blocking of Candida albicans biofilm formation by cis-2-dodecenoic acid and trans-2-dodecenoic acid.
Zhang Y; Cai C; Yang Y; Weng L; Wang L
J Med Microbiol; 2011 Nov; 60(Pt 11):1643-1650. PubMed ID: 21778264
[TBL] [Abstract][Full Text] [Related]
94. The plant-associated Bacillus amyloliquefaciens strains MEP2 18 and ARP2 3 capable of producing the cyclic lipopeptides iturin or surfactin and fengycin are effective in biocontrol of sclerotinia stem rot disease.
Alvarez F; Castro M; Príncipe A; Borioli G; Fischer S; Mori G; Jofré E
J Appl Microbiol; 2012 Jan; 112(1):159-74. PubMed ID: 22017648
[TBL] [Abstract][Full Text] [Related]
95. Anticancer Drugs as Antibiofilm Agents in Candida albicans: Potential Targets.
Wakharde AA; Halbandge SD; Phule DB; Karuppayil SM
Assay Drug Dev Technol; 2018 Jul; 16(5):232-246. PubMed ID: 29446984
[TBL] [Abstract][Full Text] [Related]
96. A Novel Variant of Narrow-Spectrum Antifungal Bacterial Lipopeptides That Strongly Inhibit Ganoderma boninense.
Pramudito TE; Agustina D; Nguyen TKN; Suwanto A
Probiotics Antimicrob Proteins; 2018 Mar; 10(1):110-117. PubMed ID: 29101528
[TBL] [Abstract][Full Text] [Related]
97. RNA aptamers selected against yeast cells inhibit Candida albicans biofilm formation in vitro.
Bachtiar BM; Srisawat C; Bachtiar EW
Microbiologyopen; 2019 Aug; 8(8):e00812. PubMed ID: 30779315
[TBL] [Abstract][Full Text] [Related]
98. Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study.
Lara HH; Romero-Urbina DG; Pierce C; Lopez-Ribot JL; Arellano-Jiménez MJ; Jose-Yacaman M
J Nanobiotechnology; 2015 Dec; 13():91. PubMed ID: 26666378
[TBL] [Abstract][Full Text] [Related]
99. Antiepileptic Drugs Inhibit Growth, Dimorphism, and Biofilm Mode of Growth in Human Pathogen Candida albicans.
Kathwate GH; Shinde RB; Karuppayil SM
Assay Drug Dev Technol; 2015; 13(6):307-12. PubMed ID: 26241210
[TBL] [Abstract][Full Text] [Related]
100. Rhamnolipid inspired lipopeptides effective in preventing adhesion and biofilm formation of Candida albicans.
Jovanovic M; Radivojevic J; O'Connor K; Blagojevic S; Begovic B; Lukic V; Nikodinovic-Runic J; Savic V
Bioorg Chem; 2019 Jun; 87():209-217. PubMed ID: 30901676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
